Infliximab-induced lupus erythematosus in a case of ulcerative colitis
Infliximab is widely used in the treatment of inflammatory bowel disease, but despite its good clinical efficacy and tolerance, drug-induced autoimmune disorders have been reported as adverse reactions and are a matter of concern. Here we report a patient with ulcerative colitis who developed drug-i...
Gespeichert in:
| Veröffentlicht in: | Nippon Shokakibyo Gakkai Zasshi 2011, Vol.108(9), pp.1535-1539 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | jpn |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1539 |
|---|---|
| container_issue | 9 |
| container_start_page | 1535 |
| container_title | Nippon Shokakibyo Gakkai Zasshi |
| container_volume | 108 |
| creator | NISHIKAWA, Jun MIYAZAKI, Takako SUZUKI, Nobuhiro ITAYA, Yuko YAMAWAKI, Hidemoto MIHARA, Hiroshi HASUMOTO, Yushi FUJINAMI, Haruka OGAWA, Kohei HOSOKAWA, Ayumu KUDO, Takahiko SUGIYAMA, Toshiro |
| description | Infliximab is widely used in the treatment of inflammatory bowel disease, but despite its good clinical efficacy and tolerance, drug-induced autoimmune disorders have been reported as adverse reactions and are a matter of concern. Here we report a patient with ulcerative colitis who developed drug-induced lupus erythematosus after infliximab treatment. While this is a rare complication of infliximab, early diagnosis and successful management are essential. |
| doi_str_mv | 10.11405/nisshoshi.108.1535 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_887757537</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>887757537</sourcerecordid><originalsourceid>FETCH-LOGICAL-j190t-e44043ee8b3d8c3f4475354931576229ab4d16fc6f348b86d48a12a74e60f0873</originalsourceid><addsrcrecordid>eNo9kF9LwzAUxYMobsx9AkH65lNn0qRp8ijDucHAF30OaXprM9J2Nqm4b2_G_rzcw4Ufh3MOQo8ELwhhOH_prPdN7xu7IFgsSE7zGzQllMm04JLeoilmjKc8F3yC5t7bEmMscykovUeTjAhJpKRTtNp0tbN_ttVlartqNFAlbtyPPoHhEBpodeh9_GyX6MRoD0lfJ6MzMOhgfyExvbPB-gd0V2vnYX7WGfpavX0u1-n2432zfN2mOyJxSIExzCiAKGklDK0ZK2JwJinJC55lUpesIrw2vKZMlIJXTGiS6YIBxzUWBZ2h55Pvfuh_RvBBtdYbcE530I9eCVEUefQ8kk9ncixbqNR-iB2Hg7pUj8D6BOx80N9wBfQQrHGgrgOrOLCSlxvzXhHT6EFBR_8B8GZ4Dg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>887757537</pqid></control><display><type>article</type><title>Infliximab-induced lupus erythematosus in a case of ulcerative colitis</title><source>MEDLINE</source><source>EZB Electronic Journals Library</source><creator>NISHIKAWA, Jun ; MIYAZAKI, Takako ; SUZUKI, Nobuhiro ; ITAYA, Yuko ; YAMAWAKI, Hidemoto ; MIHARA, Hiroshi ; HASUMOTO, Yushi ; FUJINAMI, Haruka ; OGAWA, Kohei ; HOSOKAWA, Ayumu ; KUDO, Takahiko ; SUGIYAMA, Toshiro</creator><creatorcontrib>NISHIKAWA, Jun ; MIYAZAKI, Takako ; SUZUKI, Nobuhiro ; ITAYA, Yuko ; YAMAWAKI, Hidemoto ; MIHARA, Hiroshi ; HASUMOTO, Yushi ; FUJINAMI, Haruka ; OGAWA, Kohei ; HOSOKAWA, Ayumu ; KUDO, Takahiko ; SUGIYAMA, Toshiro</creatorcontrib><description>Infliximab is widely used in the treatment of inflammatory bowel disease, but despite its good clinical efficacy and tolerance, drug-induced autoimmune disorders have been reported as adverse reactions and are a matter of concern. Here we report a patient with ulcerative colitis who developed drug-induced lupus erythematosus after infliximab treatment. While this is a rare complication of infliximab, early diagnosis and successful management are essential.</description><identifier>ISSN: 0446-6586</identifier><identifier>EISSN: 1349-7693</identifier><identifier>DOI: 10.11405/nisshoshi.108.1535</identifier><identifier>PMID: 21891993</identifier><language>jpn</language><publisher>Japan: The Japanese Society of Gastroenterology</publisher><subject>Adult ; Anti-Inflammatory Agents - adverse effects ; Antibodies, Monoclonal - adverse effects ; Colitis, Ulcerative - drug therapy ; Female ; Humans ; Infliximab ; Lupus Erythematosus, Systemic - chemically induced</subject><ispartof>Nippon Shokakibyo Gakkai Zasshi, 2011, Vol.108(9), pp.1535-1539</ispartof><rights>2011 by The Japanese Society of Gastroenterology</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21891993$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>NISHIKAWA, Jun</creatorcontrib><creatorcontrib>MIYAZAKI, Takako</creatorcontrib><creatorcontrib>SUZUKI, Nobuhiro</creatorcontrib><creatorcontrib>ITAYA, Yuko</creatorcontrib><creatorcontrib>YAMAWAKI, Hidemoto</creatorcontrib><creatorcontrib>MIHARA, Hiroshi</creatorcontrib><creatorcontrib>HASUMOTO, Yushi</creatorcontrib><creatorcontrib>FUJINAMI, Haruka</creatorcontrib><creatorcontrib>OGAWA, Kohei</creatorcontrib><creatorcontrib>HOSOKAWA, Ayumu</creatorcontrib><creatorcontrib>KUDO, Takahiko</creatorcontrib><creatorcontrib>SUGIYAMA, Toshiro</creatorcontrib><title>Infliximab-induced lupus erythematosus in a case of ulcerative colitis</title><title>Nippon Shokakibyo Gakkai Zasshi</title><addtitle>Nippon Shokakibyo Gakkai Zasshi</addtitle><description>Infliximab is widely used in the treatment of inflammatory bowel disease, but despite its good clinical efficacy and tolerance, drug-induced autoimmune disorders have been reported as adverse reactions and are a matter of concern. Here we report a patient with ulcerative colitis who developed drug-induced lupus erythematosus after infliximab treatment. While this is a rare complication of infliximab, early diagnosis and successful management are essential.</description><subject>Adult</subject><subject>Anti-Inflammatory Agents - adverse effects</subject><subject>Antibodies, Monoclonal - adverse effects</subject><subject>Colitis, Ulcerative - drug therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Infliximab</subject><subject>Lupus Erythematosus, Systemic - chemically induced</subject><issn>0446-6586</issn><issn>1349-7693</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kF9LwzAUxYMobsx9AkH65lNn0qRp8ijDucHAF30OaXprM9J2Nqm4b2_G_rzcw4Ufh3MOQo8ELwhhOH_prPdN7xu7IFgsSE7zGzQllMm04JLeoilmjKc8F3yC5t7bEmMscykovUeTjAhJpKRTtNp0tbN_ttVlartqNFAlbtyPPoHhEBpodeh9_GyX6MRoD0lfJ6MzMOhgfyExvbPB-gd0V2vnYX7WGfpavX0u1-n2432zfN2mOyJxSIExzCiAKGklDK0ZK2JwJinJC55lUpesIrw2vKZMlIJXTGiS6YIBxzUWBZ2h55Pvfuh_RvBBtdYbcE530I9eCVEUefQ8kk9ncixbqNR-iB2Hg7pUj8D6BOx80N9wBfQQrHGgrgOrOLCSlxvzXhHT6EFBR_8B8GZ4Dg</recordid><startdate>201109</startdate><enddate>201109</enddate><creator>NISHIKAWA, Jun</creator><creator>MIYAZAKI, Takako</creator><creator>SUZUKI, Nobuhiro</creator><creator>ITAYA, Yuko</creator><creator>YAMAWAKI, Hidemoto</creator><creator>MIHARA, Hiroshi</creator><creator>HASUMOTO, Yushi</creator><creator>FUJINAMI, Haruka</creator><creator>OGAWA, Kohei</creator><creator>HOSOKAWA, Ayumu</creator><creator>KUDO, Takahiko</creator><creator>SUGIYAMA, Toshiro</creator><general>The Japanese Society of Gastroenterology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201109</creationdate><title>Infliximab-induced lupus erythematosus in a case of ulcerative colitis</title><author>NISHIKAWA, Jun ; MIYAZAKI, Takako ; SUZUKI, Nobuhiro ; ITAYA, Yuko ; YAMAWAKI, Hidemoto ; MIHARA, Hiroshi ; HASUMOTO, Yushi ; FUJINAMI, Haruka ; OGAWA, Kohei ; HOSOKAWA, Ayumu ; KUDO, Takahiko ; SUGIYAMA, Toshiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j190t-e44043ee8b3d8c3f4475354931576229ab4d16fc6f348b86d48a12a74e60f0873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>jpn</language><creationdate>2011</creationdate><topic>Adult</topic><topic>Anti-Inflammatory Agents - adverse effects</topic><topic>Antibodies, Monoclonal - adverse effects</topic><topic>Colitis, Ulcerative - drug therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Infliximab</topic><topic>Lupus Erythematosus, Systemic - chemically induced</topic><toplevel>online_resources</toplevel><creatorcontrib>NISHIKAWA, Jun</creatorcontrib><creatorcontrib>MIYAZAKI, Takako</creatorcontrib><creatorcontrib>SUZUKI, Nobuhiro</creatorcontrib><creatorcontrib>ITAYA, Yuko</creatorcontrib><creatorcontrib>YAMAWAKI, Hidemoto</creatorcontrib><creatorcontrib>MIHARA, Hiroshi</creatorcontrib><creatorcontrib>HASUMOTO, Yushi</creatorcontrib><creatorcontrib>FUJINAMI, Haruka</creatorcontrib><creatorcontrib>OGAWA, Kohei</creatorcontrib><creatorcontrib>HOSOKAWA, Ayumu</creatorcontrib><creatorcontrib>KUDO, Takahiko</creatorcontrib><creatorcontrib>SUGIYAMA, Toshiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Nippon Shokakibyo Gakkai Zasshi</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>NISHIKAWA, Jun</au><au>MIYAZAKI, Takako</au><au>SUZUKI, Nobuhiro</au><au>ITAYA, Yuko</au><au>YAMAWAKI, Hidemoto</au><au>MIHARA, Hiroshi</au><au>HASUMOTO, Yushi</au><au>FUJINAMI, Haruka</au><au>OGAWA, Kohei</au><au>HOSOKAWA, Ayumu</au><au>KUDO, Takahiko</au><au>SUGIYAMA, Toshiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Infliximab-induced lupus erythematosus in a case of ulcerative colitis</atitle><jtitle>Nippon Shokakibyo Gakkai Zasshi</jtitle><addtitle>Nippon Shokakibyo Gakkai Zasshi</addtitle><date>2011-09</date><risdate>2011</risdate><volume>108</volume><issue>9</issue><spage>1535</spage><epage>1539</epage><pages>1535-1539</pages><issn>0446-6586</issn><eissn>1349-7693</eissn><abstract>Infliximab is widely used in the treatment of inflammatory bowel disease, but despite its good clinical efficacy and tolerance, drug-induced autoimmune disorders have been reported as adverse reactions and are a matter of concern. Here we report a patient with ulcerative colitis who developed drug-induced lupus erythematosus after infliximab treatment. While this is a rare complication of infliximab, early diagnosis and successful management are essential.</abstract><cop>Japan</cop><pub>The Japanese Society of Gastroenterology</pub><pmid>21891993</pmid><doi>10.11405/nisshoshi.108.1535</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0446-6586 |
| ispartof | Nippon Shokakibyo Gakkai Zasshi, 2011, Vol.108(9), pp.1535-1539 |
| issn | 0446-6586 1349-7693 |
| language | jpn |
| recordid | cdi_proquest_miscellaneous_887757537 |
| source | MEDLINE; EZB Electronic Journals Library |
| subjects | Adult Anti-Inflammatory Agents - adverse effects Antibodies, Monoclonal - adverse effects Colitis, Ulcerative - drug therapy Female Humans Infliximab Lupus Erythematosus, Systemic - chemically induced |
| title | Infliximab-induced lupus erythematosus in a case of ulcerative colitis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T14%3A53%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Infliximab-induced%20lupus%20erythematosus%20in%20a%20case%20of%20ulcerative%20colitis&rft.jtitle=Nippon%20Shokakibyo%20Gakkai%20Zasshi&rft.au=NISHIKAWA,%20Jun&rft.date=2011-09&rft.volume=108&rft.issue=9&rft.spage=1535&rft.epage=1539&rft.pages=1535-1539&rft.issn=0446-6586&rft.eissn=1349-7693&rft_id=info:doi/10.11405/nisshoshi.108.1535&rft_dat=%3Cproquest_pubme%3E887757537%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=887757537&rft_id=info:pmid/21891993&rfr_iscdi=true |